Bausch + Lomb Presents Data from First Pivotal Phase 3 Trial of Investigational Treatment NOV03 (Perfluorohexyloctane) at the American Society of Cataract and Refractive Surgery Annual Meeting
THE AESTHETIC SURGERY EDUCATION AND RESEARCH FOUNDATION ELECTS BRUCE VAN NATTA, MD AS ITS NEW PRESIDENT